Replimune Group, Inc. (REPL) insider trading

By person

7 insiders · 18 transactions

19.2×

Sushil Patel holds 19.2 times base salary in stock. $13.45M of shares against $700.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Sushil Patel last reported holding, valued at $19.00, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sushil Patel

Chief Executive Officer

—

$811.16K (3)

−$811.16K

708,151

0.8436%

$13.45M

+234.0%

Kapil Dhingra

Director

—

$441.46K (2) scheduled

−$441.46K

21,669

0.0258%

$411.71K

—

Emily Luisa Hill

Chief Financial Officer

—

$320.34K (3)

−$320.34K

215,852

0.2571%

$4.10M

+113.6%

Konstantinos Xynos

Chief Medical Officer

—

$285.66K (3)

−$285.66K

224,215

0.2671%

$4.26M

+91.4%

Christopher Sarchi

Chief Commercial Officer

—

$254.16K (4) scheduled

−$254.16K

180,962

0.2156%

$3.44M

+96.2%

Andrew Schwendenman

Chief Accounting Officer

—

$139.09K (2)

−$139.09K

99,425

0.1184%

$1.89M

−44.2%

Philip Astley-Sparke

Director

—

$89.70K (1)

−$89.70K

1,362,414

1.62%

$25.89M

−5.2%

Replimune Group, Inc.

What the insiders did Net selling

By person